InvestorsHub Logo

BottomBounce

08/13/20 8:26 PM

#9417 RE: BottomBounce #9368

$GILD Gilead is working closely with global health authorities to respond to the novel coronavirus (COVID-19) outbreak through the appropriate use of the investigational drug remdesivir. Together with the U.S. Food and Drug Administration (FDA), Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (DHHS), National Institute of Allergies and Infectious Diseases (NIAID) and Department of Defense (DoD) - CBRN Medical; the China CDC and National Medical Product Administration (NMPA); the World Health Organization (WHO); and researchers and clinicians across Europe and Asia; Gilead is focused on contributing our antiviral expertise and resources to help patients and communities fighting COVID-19.

https://www.gilead.com/purpose/advancing-global-health/covid-19